Mysimba
Active substance: bupropion hydrochloride, naltrexone hydrochloride
bupropion hydrochloride, naltrexone hydrochloride
Centralised EU authorisationActive
Marketing holder: Orexigen Therapeutics Ireland Limited
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Products containing Bupropion in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| US 350 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-273b-7bad-8eff-8a7560f1e9c0,01a1208c-2752-724b-8f94-0f16aa40c3a4,01a1208c-29db-7d45-b421-b9aa063fde8b,01a1208c-2cfe-72dd-9a88-34a9c272d0ab,01a1208c-328f-775e-9927-8c2eeaac0396;count=347 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/003687
- Registration status
- Active
- ATC code
- A08AA
Sources
- product · EMA · EMEA/H/C/003687 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/003687 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/003687 · Verified 2026-10-09
- ingredients.1 · EMA · EMEA/H/C/003687 · Verified 2026-10-09